Glioma and Extracellular Matrix

作者: Christian Mawrin , Constanze Seidenbecher

DOI: 10.1007/978-3-7091-1431-5_10

关键词:

摘要: Invasion of glioma cells into brain tissue involves a multitude molecular interactions invading with host and the surrounding extracellular matrix (ECM). The ECM is complex structure composed proteoglycans glycoproteins glial neuronal origin, which largely based on hyaluronic acid (HA) as central organizing glycosaminoglycan. It particularly rich in different carbohydrate epitopes undergoes developmental shift around synaptogenesis terminal maturation. Glioma do not only bind to components via specific receptors are highly expressed their surfaces but they actively shape by secreting constituents ECM-modulating enzymes like proteases, glycosidases, or sulfatases, thus creating permissive environment. Proteomic approaches have shown that individual secretomes can vary composition. This mutual glioma–host–ECM interaction, also microvasculature brain, contributes devastating nature tumors, because it enables malignant pave way parenchyma. normal well glioma-derived makes challenging identify entry points for successful therapeutic treatment. First attempts targeting technological change biomechanical properties promising need more time.

参考文章(102)
H. J. Scherer, Structural Development in Gliomas American Journal of Cancer. ,vol. 34, pp. 333- 351 ,(1938) , 10.1158/AJC.1938.333
Yasuhiko Akiyama, Shin Jung, Bodour Salhia, Sangpyung Lee, Sherrilynn Hubbard, Michael Taylor, Todd Mainprize, Kotaro Akaishi, Wouter van Furth, James T. Rutka, Hyaluronate receptors mediating glioma cell migration and proliferation. Journal of Neuro-oncology. ,vol. 53, pp. 115- 127 ,(2001) , 10.1023/A:1012297132047
Joseph M. Piepmeier, Gail M. Kelly, Susan Hockfield, Diane M. Jaworski, BEHAB (Brain Enriched Hyaluronan Binding) Is Expressed in Surgical Samples of Glioma and in Intracranial Grafts of Invasive Glioma Cell Lines Cancer Research. ,vol. 56, pp. 2293- 2298 ,(1996)
Abraham Noorbakhsh, Jessica A. Tang, Logan P. Marcus, Brandon McCutcheon, David D. Gonda, Craig S. Schallhorn, Mark A. Talamini, David C. Chang, Bob S. Carter, Clark C. Chen, Gross-total resection outcomes in an elderly population with glioblastoma: a SEER-based analysis Journal of Neurosurgery. ,vol. 120, pp. 31- 39 ,(2014) , 10.3171/2013.9.JNS13877
Annie Laquerriere, Catherine Maingonnat, Philippe Bertrand, Pierre Freger, Bertrand Delpech, Hyaluronidase is more elevated in human brain metastases than in primary brain tumours. Anticancer Research. ,vol. 22, pp. 2423- 2427 ,(2002)
Vinata B. Lokeshwar, Wolfgang H. Cerwinka, Tadahiro Isoyama, Bal L. Lokeshwar, HYAL1 Hyaluronidase in Prostate Cancer: A Tumor Promoter and Suppressor Cancer Research. ,vol. 65, pp. 7782- 7789 ,(2005) , 10.1158/0008-5472.CAN-05-1022
Paul E.G. Kristjansen, Nanna Junker, Scilla Latini, Lone N. Petersen, Expression and regulation patterns of hyaluronidases in small cell lung cancer and glioma lines Oncology Reports. ,vol. 10, pp. 609- 616 ,(2003) , 10.3892/OR.10.3.609
Claudia Scaringi, Giuseppe Minniti, Riccardo Maurizi Enrici, Paola Caporello, Integrin Inhibitor Cilengitide for the Treatment of Glioblastoma: A Brief Overview of Current Clinical Results Anticancer Research. ,vol. 32, pp. 4213- 4223 ,(2012)
Chirag G. Patil, Anthony Yi, Adam Elramsisy, Jethro Hu, Debraj Mukherjee, Dwain K. Irvin, John S. Yu, Serguei I. Bannykh, Keith L. Black, Miriam Nuño, Prognosis of patients with multifocal glioblastoma: a case-control study. Journal of Neurosurgery. ,vol. 117, pp. 705- 711 ,(2012) , 10.3171/2012.7.JNS12147